Bookbot

IARC Scientific Publications - 154: Biomarkers in Cancer Chemoprevention

Parametry

  • 304 strony
  • 11 godzin czytania

Więcej o książce

The evaluation of potential cancer chemopreventive agents require large, long-term, randomized trials in humans. Biomarkers that would allow the identification of subjects exposed to carcinogenic agents, or of individuals genetically, susceptible to cancer would be of great value. This volume is the product of an attempt to assess current knowledge and experience with the use of biomarkers in cancer chemoprevention. It comprises an expert report on the current state of the art use of biomarkers in cancer chemoprevention, introductory sections covering general topics in cancer chemoprevention, and contributions, directed to biomarkers of exposure, intermediate effect and susceptibility relating to six major cancer sites: skin, colorectum, breast, prostate, liver, and upper aerodigestive tract.

Zakup książki

IARC Scientific Publications - 154: Biomarkers in Cancer Chemoprevention, Anthony B. Miller, Hella Bartsch, Paolo Boffetta, L Dragsted, H. Vainio

Język
Rok wydania
2001
Oprawa
(miękka),
Stan książki
Uszkodzony
Cena
13,01 zł

Metody płatności

Nikt jeszcze nie ocenił.Oceń

Tytuł
IARC Scientific Publications - 154: Biomarkers in Cancer Chemoprevention
Język
angielski
Rok wydania
2001
Oprawa
miękka
Liczba stron
304
ISBN10
9283221540
ISBN13
9789283221548
Seria
Opis
The evaluation of potential cancer chemopreventive agents require large, long-term, randomized trials in humans. Biomarkers that would allow the identification of subjects exposed to carcinogenic agents, or of individuals genetically, susceptible to cancer would be of great value. This volume is the product of an attempt to assess current knowledge and experience with the use of biomarkers in cancer chemoprevention. It comprises an expert report on the current state of the art use of biomarkers in cancer chemoprevention, introductory sections covering general topics in cancer chemoprevention, and contributions, directed to biomarkers of exposure, intermediate effect and susceptibility relating to six major cancer sites: skin, colorectum, breast, prostate, liver, and upper aerodigestive tract.